Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Sulfamide | HCID 82267 | — |
| Reactant | HCID 69266958 | HCID 69266958 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | HCID 178514777 | HCID 178514777 | 50.7% |
Reaction Steps
3-[4-(Aminomethyl)-1,2,5-oxadiazol-3-yl]-4-(3-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one trifluoroacetate (30 mg, 0.07 mmol) and sulfamide (20 mg, 0.2 mmol) was dissolved in pyridine (1.0 mL) and heated at 120° C. for 3 min in a microwave. A solution of sodium hydroxide in water (0.5 mL, 1 N) was added and the solution was stirred for 30 minutes. Acidification with acetic acid and purification by preparative LCMS gave the desired product (17 mg, 50%). MF═C10H10ClFN6O4S; LCMS calculated for C10H11ClFN6O4S(M+H)+: m/z=364.9. 1H NMR (400 MHz, CD3OD): δ 7.02 (m, 2H), 6.76 (m, 1H), 4.50 (s, 2H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08450351B2 |
|---|
| Source dataset | uspto-grants-2013_05 |
|---|
| ORD ID | ord-867d6dcf1f5e4217a52a2cf8bb13ad58 |
|---|
| Source note | uspto-grants-2013_05 |
|---|